
Pheton (NASDAQ: PTHL)
$21.10
(0.8%)
$0.16
Price as of July 17, 2025, 12:40 p.m. ET
Pheton Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Pheton Company Info
Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.